CB2: a cannabinoid receptor with an identity crisis

被引:441
|
作者
Atwood, Brady K. [1 ,2 ,3 ]
Mackie, Ken [1 ,2 ]
机构
[1] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA
[2] Indiana Univ, Gill Ctr, Bloomington, IN 47405 USA
[3] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA
关键词
GPCR tissue distribution; microglia; sensory neurons; pain; immunocytochemistry; LIPOPOLYSACCHARIDE-TREATED RATS; TRABECULAR MESHWORK CELLS; CENTRAL-NERVOUS-SYSTEM; DORSAL-HORN NEURONS; PAIN MODELS; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; NEUROPATHIC PAIN; INVERSE AGONIST; SENSORY NEURONS;
D O I
10.1111/j.1476-5381.2010.00729.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article is part of a themed issue on Cannabinoids. To view the editorial for this themed issue visit http://dx.doi.org/10.1111/j.1476-5381.2010.00831.x.
引用
收藏
页码:467 / 479
页数:13
相关论文
共 50 条
  • [31] Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor**
    Morales, Paula
    Navarro, Gemma
    Gomez-Autet, Marc
    Redondo, Laura
    Fernandez-Ruiz, Javier
    Perez-Benito, Laura
    Cordomi, Arnau
    Pardo, Leonardo
    Franco, Rafael
    Jagerovic, Nadine
    [J]. CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (68) : 15839 - 15842
  • [32] The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update
    Rakotoarivelo, Volatiana
    Mayer, Thomas Z.
    Simard, Melissa
    Flamand, Nicolas
    Di Marzo, Vincenzo
    [J]. MOLECULES, 2024, 29 (14):
  • [33] ROLE OF CANNABINOID CB2 RECEPTOR IN THE REINFORCING ACTIONS OF ETHANOL
    Garcia-Gutierrez, M. S.
    Navarrete, F.
    Aracil-Fernandez, A.
    Ortega-Alvaro, A.
    Ternianov, A.
    Manzanares, J.
    [J]. ALCOHOL AND ALCOHOLISM, 2015, 50
  • [34] Structural basis of selective cannabinoid CB2 receptor activation
    Xiaoting Li
    Hao Chang
    Jara Bouma
    Laura V. de Paus
    Partha Mukhopadhyay
    Janos Paloczi
    Mohammed Mustafa
    Cas van der Horst
    Sanjay Sunil Kumar
    Lijie Wu
    Yanan Yu
    Richard J. B. H. N. van den Berg
    Antonius P. A. Janssen
    Aron Lichtman
    Zhi-Jie Liu
    Pal Pacher
    Mario van der Stelt
    Laura H. Heitman
    Tian Hua
    [J]. Nature Communications, 14
  • [35] CANNABINOID RECEPTOR CB2 AND IMMUNE MODULATION OF HEPATIC FIBROSIS
    Avraham, Yosefa
    Doron, Sarit
    Mahmud, Mahamid N.
    Berry, Elliot M.
    Safadi, Rifaat
    [J]. HEPATOLOGY, 2008, 48 (04) : 911A - 911A
  • [36] Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands
    Worm, Karin
    Zhou, Q. Jean
    Saeui, Christopher T.
    Green, Rosalyn C.
    Cassel, Joel A.
    Stabley, Gabriel J.
    DeHaven, Robert N.
    Conway-James, Nathalie
    LaBuda, Christopher J.
    Koblish, Michael
    Little, Patrick J.
    Dolle, Roland E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2830 - 2835
  • [37] Cloning and molecular characterization of the rat CB2 cannabinoid receptor
    Brown, SM
    Wager-Miller, J
    Mackie, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1576 (03): : 255 - 264
  • [38] Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol
    Ortega-Alvaro, Antonio
    Ternianov, Alexander
    Aracil-Fernandez, Auxiliadora
    Navarrete, Francisco
    Salud Garcia-Gutierrez, Maria
    Manzanares, Jorge
    [J]. ADDICTION BIOLOGY, 2015, 20 (01) : 43 - 55
  • [39] Knockout controls and the specificity of cannabinoid CB2 receptor antibodies
    Ashton, John C.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) : 1113 - 1113
  • [40] Role of cannabinoid CB2 receptor in Parkinson's disease
    Navarrete Rueda, F.
    Garcia-Gutierrez, M. S.
    Aracil-Fernandez, A.
    Molina-Arjona, J. A.
    Leiva-Santana, C.
    Manzanares, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S646 - S647